Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.4053
-0.0418 (-9.35%)
At close: Oct 9, 2026, 4:00 PM EDT
0.4200
+0.0147 (3.63%)
After-hours: Oct 9, 2026, 7:52 PM EDT
Humacyte Market Cap
Humacyte has a market cap or net worth of $112.59 million as of October 9, 2026. It is the 24,611th most valuable company in the world and the 4,030th biggest in the United States. Its market cap has decreased by 64.42% in one year.
Market Cap
112.59M
Enterprise Value
99.57M
1-Year Change
-64.42%
Global Rank
Country Rank
#4,030 United States
Category
ChartMarket Cap Chart
Since December 1, 2020, Humacyte's market cap has decreased from $124.31M to $112.59M, a decrease of -9.43%. That is a compound annual growth rate of -1.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 112.59M | -39.26% |
| Dec 31, 2025 | 185.37M | -71.47% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inovio Pharmaceuticals | 115.29M |
| Unicycive Therapeutics | 115.04M |
| Coya Therapeutics | 114.71M |
| LENZ Therapeutics | 114.37M |
| Genelux | 113.37M |
| Vivani Medical | 112.75M |
| Tevogen | 112.52M |
| Immunic | 111.61M |